Vaccine

Piramal Pharma Limited Announces Results for Q4 and FY2025Piramal Pharma Limited Announces Results for Q4 and FY2025

Piramal Pharma Limited Announces Results for Q4 and FY2025

MUMBAI, India, May 14, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness…

4 weeks ago
IO Biotech Reports First Quarter 2025 Financial Results and Business HighlightsIO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still…

4 weeks ago
Rapid Dose Announces Proposed Debt SettlementRapid Dose Announces Proposed Debt Settlement

Rapid Dose Announces Proposed Debt Settlement

Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that…

1 month ago
Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025

Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025

WASHINGTON, May 9, 2025 /PRNewswire/ -- Dr. Edward Robb, Chief Strategy Officer, Anivive Lifesciences presented their pioneering research update on…

1 month ago
Ocugen Provides Business Update with First Quarter 2025 Financial ResultsOcugen Provides Business Update with First Quarter 2025 Financial Results

Ocugen Provides Business Update with First Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing…

1 month ago
Dario’s Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk PopulationsDario’s Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations

Dario’s Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations

New data, published in JMIR, demonstrates the value of personalized messaging encouraging flu vaccinations in Dario members with diabetes NEW…

1 month ago
Alpha Pro Tech, Ltd. Announces First Quarter 2025 Financial ResultsAlpha Pro Tech, Ltd. Announces First Quarter 2025 Financial Results

Alpha Pro Tech, Ltd. Announces First Quarter 2025 Financial Results

Total Sales Increased by 2.5% to $13.8 Million, Compared to the Prior Year PeriodNet sales for the first quarter of…

1 month ago
Novavax to Participate in BofA Securities 2025 Health Care ConferenceNovavax to Participate in BofA Securities 2025 Health Care Conference

Novavax to Participate in BofA Securities 2025 Health Care Conference

GAITHERSBURG, Md., May 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA…

1 month ago
BioVaxys and Sona Nanotech Enter Research CollaborationBioVaxys and Sona Nanotech Enter Research Collaboration

BioVaxys and Sona Nanotech Enter Research Collaboration

Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB)…

1 month ago